Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study
Despite lower recurrence-free survival during the first year among those with inflammatory bowel disease, there were no long-term differences between patients with or without inflammatory bowel disease.
Authors
- Erik Lundqvist (ORCID: https://orcid.org/0000-0001-5312-1023)
- Pär Myrelid (ORCID: https://orcid.org/0000-0001-7518-9213)
- Asa Hallqvist Everhov (ORCID: https://orcid.org/0000-0002-0311-8894)
- Karin Westberg (ORCID: https://orcid.org/0000-0003-3690-5349)
- Bengt Glimelius (ORCID: https://orcid.org/0000-0002-5440-791X)
- Caroline A.M. Nordenvall (ORCID: https://orcid.org/0000-0002-5112-8894)
- Anna Martling (ORCID: https://orcid.org/0000-0001-5998-4735)
- Caroline E. Dietrich
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
- Vrinnevisjukhuset i Norrköping (SE)
- Linköping University Hospital (SE)
Publication Details
- Journal
- BJS Open
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1093/bjsopen/zraf014
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Forskningsrådet i Sydöstra Sverige
- Insamlingsstiftelsen Cancer- och Allergifonden
- Cancerfonden
- Cancerföreningen i Stockholm
- Bengt Ihres Foundation
- Medical Research Council